plane wart. Verruca: simplex vulgaris
Conditions
Interventions
Intervention 1: Intervention group 1: The group which is treated with potassium hydroxide 10% (KOH) weekly for 12 weeks. The drug is produced by Merck company, Germany. The drug code is 1.05032.1000.
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
4 Years to No maximum
Inclusion criteria
Inclusion criteria: being at the age of 4 years old and over Number of warts 3-30
Exclusion criteria
Exclusion criteria: Pregnancy Breast feeding High wart count (more than 30) Hypersensitivity to KOH or TCA Unable to return for follow up Other treatment in the previous one month
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wart Number. Timepoint: Before intervention, 4, 8, 12 weeks after intervention, 1 month after full response. Method of measurement: Number.;Wart size. Timepoint: Before intervention, 4, 8, 12 weeks after intervention, 1 month after full response. Method of measurement: Ruller. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBahareh Maleki
Ahvaz University of Medical Sciences
Outcome results
None listed